<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3AGlucagon-like_peptide-1%2F3%2Fen</id>
	<title>Translations:Glucagon-like peptide-1/3/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3AGlucagon-like_peptide-1%2F3%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Glucagon-like_peptide-1/3/en&amp;action=history"/>
	<updated>2026-10-08T23:55:36Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Translations:Glucagon-like_peptide-1/3/en&amp;diff=127230&amp;oldid=prev</id>
		<title>FuzzyBot: Importing a new version from external source</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Glucagon-like_peptide-1/3/en&amp;diff=127230&amp;oldid=prev"/>
		<updated>2024-03-11T00:48:14Z</updated>

		<summary type="html">&lt;p&gt;Importing a new version from external source&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Alongside [[glucose-dependent insulinotropic peptide]] (GIP), GLP-1 is an [[incretin]]; thus, it has the ability to decrease [[blood sugar levels]] in a glucose-dependent manner by enhancing the [[secretion]] of [[insulin]]. Beside the insulinotropic effects, GLP-1 has been associated with numerous regulatory and protective effects. Unlike GIP, the action of GLP-1 is preserved in patients with [[type 2 diabetes]]. [[Glucagon-like peptide-1 receptor agonist]]s gained approval as drugs to treat diabetes and obesity starting in the 2000s.&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>